Literature DB >> 22528625

Dietary soy protein induces hepatic lipogenic enzyme gene expression while suppressing hepatosteatosis in obese female Zucker rats bearing DMBA-initiated mammary tumors.

Reza Hakkak1, Ahmed Al-Dwairi, George J Fuchs, Soheila Korourian, Frank A Simmen.   

Abstract

Fatty liver is associated with obesity and breast cancer. We used an obese rat model of mammary cancer to examine whether hepatosteatosis is modifiable by diet and associated with altered expression of hepatic lipogenic enzyme genes, thyroid hormone system genes and cholesterol metabolism-related genes. Beginning at the age of 5 weeks, lean and obese female Zucker rats were fed high-isoflavone soy protein- or casein (control protein)-containing diets. Rats were euthanized at 200 days of age [corresponding to 147 days after administration of carcinogen to induce mammary tumors; (Hakkak et al. in, Oncol Lett 2:29-36, 2011)]. Obese rats had a greater degree of liver steatosis than lean rats. Obese casein-fed rats had marked steatosis with small foci of mononuclear infiltration, whereas obese soy protein-fed rats had a significantly lower steatosis index. Comparisons between lean and obese casein-fed rats showed that obesity was associated with significant reductions in hepatic mRNA abundance for Glucose 6-Phosphate Dehydrogenase (G6PD), 6-Phosphogluconate Dehydrogenase (6PGD), Thyroid Receptor Alpha 1 (TRα1), Thyroid Receptor Beta 1 (TRβ1) and Iodothyronine Deiodinase 1 (DIO1). The soy protein diet was associated with increased expression of Fatty Acid Synthase (FASN), Malic Enzyme 1 (ME1), 6PGD, Sterol Regulatory Element Binding Protein-1c (SREBP-1c) and SREBP-2 genes in the livers of obese but not lean rats. Western blot analysis showed a significant induction of ME1 protein expression in the livers of obese, soy protein-fed rats, which paralleled the increased serum insulin level in this group. Long-term soy protein consumption can counter hepatic steatosis while coincidently promoting hepatic lipogenic gene expression, the latter likely a consequence of elevated serum insulin. We suggest that elevations in serum insulin, hepatic lipogenesis and cholesterol synthesis all contributed to the increased tumorigenesis previously observed for the obese, soy protein-fed rats.

Entities:  

Year:  2012        PMID: 22528625      PMCID: PMC3448032          DOI: 10.1007/s12263-012-0294-6

Source DB:  PubMed          Journal:  Genes Nutr        ISSN: 1555-8932            Impact factor:   5.523


  36 in total

1.  Fat accretion and growth in the rat.

Authors:  T F Zucker; L M Zucker
Journal:  J Nutr       Date:  1963-05       Impact factor: 4.798

Review 2.  Treatment of nonalcoholic fatty liver disease.

Authors:  Paul Angulo
Journal:  Ann Hepatol       Date:  2002 Jan-Mar       Impact factor: 2.400

Review 3.  Experimental obesity: a homeostatic failure due to defective nutrient stimulation of the sympathetic nervous system.

Authors:  G A Bray; D A York; J S Fisler
Journal:  Vitam Horm       Date:  1989       Impact factor: 3.421

4.  Relationships between tamoxifen use, liver fat and body fat distribution in women with breast cancer.

Authors:  M C Nguyen; R B Stewart; M A Banerji; D H Gordon; J G Kral
Journal:  Int J Obes Relat Metab Disord       Date:  2001-02

5.  Effects of high-isoflavone soy diet vs. casein protein diet and obesity on DMBA-induced mammary tumor development.

Authors:  Reza Hakkak; Saied Shaaf; Chan Hee Jo; Stewart Macleod; Soheila Korourian
Journal:  Oncol Lett       Date:  2010-11-08       Impact factor: 2.967

6.  Dietary soya protein concentrate enriched with isoflavones reduced fatty liver, increased hepatic fatty acid oxidation and decreased the hepatic mRNA level of VLDL receptor in obese Zucker rats.

Authors:  Oddrun A Gudbrandsen; Hege Wergedahl; Sverre Mørk; Bjørn Liaset; Marit Espe; Rolf K Berge
Journal:  Br J Nutr       Date:  2006-08       Impact factor: 3.718

7.  A soy protein diet alters hepatic lipid metabolism gene expression and reduces serum lipids and renal fibrogenic cytokines in rats with chronic nephrotic syndrome.

Authors:  Armando R Tovar; Fernanda Murguía; Cristino Cruz; Rogelio Hernández-Pando; Carlos A Aguilar-Salinas; José Pedraza-Chaverri; Ricardo Correa-Rotter; Nimbe Torres
Journal:  J Nutr       Date:  2002-09       Impact factor: 4.798

8.  Fatty metamorphosis of the liver in patients with breast cancer: possible associated factors.

Authors:  Cheng-Hsin Chu; Shee-Chan Lin; Shou-Chuan Shih; Chin-Roa Kao; Sun-Yen Chou
Journal:  World J Gastroenterol       Date:  2003-07       Impact factor: 5.742

9.  Fat mobilization in vitro and in vivo in the genetically obese Zucker rat "fatty".

Authors:  L M Zucker
Journal:  J Lipid Res       Date:  1972-03       Impact factor: 5.922

10.  Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes.

Authors:  Jo Vandesompele; Katleen De Preter; Filip Pattyn; Bruce Poppe; Nadine Van Roy; Anne De Paepe; Frank Speleman
Journal:  Genome Biol       Date:  2002-06-18       Impact factor: 13.583

View more
  10 in total

Review 1.  Mammalian models of chemically induced primary malignancies exploitable for imaging-based preclinical theragnostic research.

Authors:  Yewei Liu; Ting Yin; Yuanbo Feng; Marlein Miranda Cona; Gang Huang; Jianjun Liu; Shaoli Song; Yansheng Jiang; Qian Xia; Johannes V Swinnen; Guy Bormans; Uwe Himmelreich; Raymond Oyen; Yicheng Ni
Journal:  Quant Imaging Med Surg       Date:  2015-10

2.  Dietary supplementation with soy isoflavones or replacement with soy proteins prevents hepatic lipid droplet accumulation and alters expression of genes involved in lipid metabolism in rats.

Authors:  Chao Wu Xiao; Carla M Wood; Dorcas Weber; Syed A Aziz; Rekha Mehta; Philip Griffin; Kevin A Cockell
Journal:  Genes Nutr       Date:  2013-11-30       Impact factor: 5.523

3.  Cytosolic malic enzyme 1 (ME1) mediates high fat diet-induced adiposity, endocrine profile, and gastrointestinal tract proliferation-associated biomarkers in male mice.

Authors:  Ahmed Al-Dwairi; John Mark P Pabona; Rosalia C M Simmen; Frank A Simmen
Journal:  PLoS One       Date:  2012-10-04       Impact factor: 3.240

4.  Short-Term Metformin Treatment Enriches Bacteroides dorei in an Obese Liver Steatosis Zucker Rat Model.

Authors:  Michael S Robeson; Kanishka Manna; Christopher Randolph; Stephanie Byrum; Reza Hakkak
Journal:  Front Microbiol       Date:  2022-03-30       Impact factor: 5.640

5.  Assessment of gut microbiota populations in lean and obese Zucker rats.

Authors:  Reza Hakkak; Soheila Korourian; Steven L Foley; Bruce D Erickson
Journal:  PLoS One       Date:  2017-07-13       Impact factor: 3.240

6.  Effects of Obesity on Pro-Oxidative Conditions and DNA Damage in Liver of DMBA-Induced Mammary Carcinogenesis Models.

Authors:  Stepan Melnyk; Soheila Korourian; Joseph W Levy; Oleksandra Pavliv; Teresa Evans; Reza Hakkak
Journal:  Metabolites       Date:  2017-06-08

7.  Dehydroepiandrosterone (DHEA) Feeding Protects Liver Steatosis in Obese Breast Cancer Rat Model.

Authors:  Reza Hakkak; Andrea Bell; Soheila Korourian
Journal:  Sci Pharm       Date:  2017-03-20

8.  Diet Containing Soy Protein Concentrate With Low and High Isoflavones for 9 Weeks Protects Against Non-alcoholic Fatty Liver Steatosis Using Obese Zucker Rats.

Authors:  Reza Hakkak; Beverly Spray; Elisabet Børsheim; Soheila Korourian
Journal:  Front Nutr       Date:  2022-06-22

Review 9.  Hypolipidemic Effects of Soy Protein and Isoflavones in the Prevention of Non-Alcoholic Fatty Liver Disease- A Review.

Authors:  Chao-Wu Xiao; Amy Hendry
Journal:  Plant Foods Hum Nutr       Date:  2022-06-09       Impact factor: 4.124

10.  Short-Term Soy Protein Isolate Feeding Prevents Liver Steatosis and Reduces Serum ALT and AST Levels in Obese Female Zucker Rats.

Authors:  Reza Hakkak; Clinton Heath Gauss; Andrea Bell; Soheila Korourian
Journal:  Biomedicines       Date:  2018-05-14
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.